Physician profile
Daniel David Day
NPI 1710136411
$1,867.44
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $879 · 2022: $39.41 · 2023: $897 · 2024: $52.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $779 · Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $778.87 |
| Food and Beverage | $170.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $879.13 | 2021 | |
| Prodigy Surgical Distribution, INC. | $618.49 | 2023 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Smith+Nephew, INC. | $52.33 | 2024 | |
| Ferring Pharmaceuticals INC. | $39.41 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.